198 related articles for article (PubMed ID: 35460011)
1. Energetic metabolic reprogramming in Jurkat DFF40-deficient cancer cells.
Kulbay M; Johnson B; Ricaud G; Séguin-Grignon MN; Bernier J
Mol Cell Biochem; 2022 Sep; 477(9):2213-2233. PubMed ID: 35460011
[TBL] [Abstract][Full Text] [Related]
2. DNA fragmentation factor 40 expression in T cells confers sensibility to tributyltin-induced apoptosis.
Kulbay M; Johnson B; Bernier J
Toxicology; 2019 Oct; 426():152255. PubMed ID: 31401084
[TBL] [Abstract][Full Text] [Related]
3. Caspase-activated DNase is necessary and sufficient for oligonucleosomal DNA breakdown, but not for chromatin disassembly during caspase-dependent apoptosis of LN-18 glioblastoma cells.
Sánchez-Osuna M; Garcia-Belinchón M; Iglesias-Guimarais V; Gil-Guiñón E; Casanelles E; Yuste VJ
J Biol Chem; 2014 Jul; 289(27):18752-69. PubMed ID: 24838313
[TBL] [Abstract][Full Text] [Related]
4. Apoptotic DNA degradation into oligonucleosomal fragments, but not apoptotic nuclear morphology, relies on a cytosolic pool of DFF40/CAD endonuclease.
Iglesias-Guimarais V; Gil-Guiñon E; Gabernet G; García-Belinchón M; Sánchez-Osuna M; Casanelles E; Comella JX; Yuste VJ
J Biol Chem; 2012 Mar; 287(10):7766-79. PubMed ID: 22253444
[TBL] [Abstract][Full Text] [Related]
5. Curcumin induces caspase-3-dependent apoptotic pathway but inhibits DNA fragmentation factor 40/caspase-activated DNase endonuclease in human Jurkat cells.
Sikora E; Bielak-Zmijewska A; Magalska A; Piwocka K; Mosieniak G; Kalinowska M; Widlak P; Cymerman IA; Bujnicki JM
Mol Cancer Ther; 2006 Apr; 5(4):927-34. PubMed ID: 16648563
[TBL] [Abstract][Full Text] [Related]
6. Caspase-activated DNase/DNA fragmentation factor 40 mediates apoptotic DNA fragmentation in transient cerebral ischemia and in neuronal cultures.
Cao G; Pei W; Lan J; Stetler RA; Luo Y; Nagayama T; Graham SH; Yin XM; Simon RP; Chen J
J Neurosci; 2001 Jul; 21(13):4678-90. PubMed ID: 11425895
[TBL] [Abstract][Full Text] [Related]
7. DFF40 deficiency in cancerous T cells is implicated in chemotherapy drug sensitivity and resistance through the regulation of the apoptotic pathway.
Kulbay M; Johnson B; Fiola S; Diaz RJ; Bernier J
Biochem Pharmacol; 2021 Dec; 194():114801. PubMed ID: 34678222
[TBL] [Abstract][Full Text] [Related]
8. T and B leukemic cell lines exhibit different requirements for cell death: correlation between caspase activation, DFF40/DFF45 expression, DNA fragmentation and apoptosis in T cell lines but not in Burkitt's lymphoma.
Luciano F; Ricci JE; Herrant M; Bertolotto C; Mari B; Cousin JL; Auberger P
Leukemia; 2002 Apr; 16(4):700-7. PubMed ID: 11960352
[TBL] [Abstract][Full Text] [Related]
9. An intrinsic DFF40/CAD endonuclease deficiency impairs oligonucleosomal DNA hydrolysis during caspase-dependent cell death: a common trait in human glioblastoma cells.
Sánchez-Osuna M; Martínez-Escardó L; Granados-Colomina C; Martínez-Soler F; Pascual-Guiral S; Iglesias-Guimarais V; Velasco R; Plans G; Vidal N; Tortosa A; Barcia C; Bruna J; Yuste VJ
Neuro Oncol; 2016 Jul; 18(7):950-61. PubMed ID: 26755073
[TBL] [Abstract][Full Text] [Related]
10. The DFF40/CAD endonuclease and its role in apoptosis.
Widłak P
Acta Biochim Pol; 2000; 47(4):1037-44. PubMed ID: 11996094
[TBL] [Abstract][Full Text] [Related]
11. Non-endometrioid and high-grade endometrioid endometrial cancers show DNA fragmentation factor 40 (DFF40) and B-cell lymphoma 2 protein (BCL2) underexpression, which predicts disease-free and overall survival, but not DNA fragmentation factor 45 (DFF45) underexpression.
Banas T; Pitynski K; Okon K; Winiarska A
BMC Cancer; 2018 Apr; 18(1):418. PubMed ID: 29653556
[TBL] [Abstract][Full Text] [Related]
12. Chromatin collapse during caspase-dependent apoptotic cell death requires DNA fragmentation factor, 40-kDa subunit-/caspase-activated deoxyribonuclease-mediated 3'-OH single-strand DNA breaks.
Iglesias-Guimarais V; Gil-Guiñon E; Sánchez-Osuna M; Casanelles E; García-Belinchón M; Comella JX; Yuste VJ
J Biol Chem; 2013 Mar; 288(13):9200-15. PubMed ID: 23430749
[TBL] [Abstract][Full Text] [Related]
13. Structural mechanism for inactivation and activation of CAD/DFF40 in the apoptotic pathway.
Woo EJ; Kim YG; Kim MS; Han WD; Shin S; Robinson H; Park SY; Oh BH
Mol Cell; 2004 May; 14(4):531-9. PubMed ID: 15149602
[TBL] [Abstract][Full Text] [Related]
14. Modulation of DNA fragmentation factor 40 nuclease activity by poly(ADP-ribose) polymerase-1.
West JD; Ji C; Marnett LJ
J Biol Chem; 2005 Apr; 280(15):15141-7. PubMed ID: 15703174
[TBL] [Abstract][Full Text] [Related]
15. Identification of regulatory and catalytic domains in the apoptosis nuclease DFF40/CAD.
Inohara N; Koseki T; Chen S; Benedict MA; Núñez G
J Biol Chem; 1999 Jan; 274(1):270-4. PubMed ID: 9867840
[TBL] [Abstract][Full Text] [Related]
16. Activation of the apoptotic endonuclease DFF40 (caspase-activated DNase or nuclease). Oligomerization and direct interaction with histone H1.
Liu X; Zou H; Widlak P; Garrard W; Wang X
J Biol Chem; 1999 May; 274(20):13836-40. PubMed ID: 10318789
[TBL] [Abstract][Full Text] [Related]
17. Caspase-3 is the primary activator of apoptotic DNA fragmentation via DNA fragmentation factor-45/inhibitor of caspase-activated DNase inactivation.
Wolf BB; Schuler M; Echeverri F; Green DR
J Biol Chem; 1999 Oct; 274(43):30651-6. PubMed ID: 10521451
[TBL] [Abstract][Full Text] [Related]
18. Sensitization of breast cancer cells to doxorubicin via stable cell line generation and overexpression of DFF40.
Bagheri F; Safarian S; Eslaminejad MB; Sheibani N
Biochem Cell Biol; 2015 Dec; 93(6):604-10. PubMed ID: 26529233
[TBL] [Abstract][Full Text] [Related]
19. Coordinate expression of apoptosis-associated proteins in human breast cancer before and during chemotherapy.
Parton M; Krajewski S; Smith I; Krajewska M; Archer C; Naito M; Ahern R; Reed J; Dowsett M
Clin Cancer Res; 2002 Jul; 8(7):2100-8. PubMed ID: 12114409
[TBL] [Abstract][Full Text] [Related]
20. Functional interaction of DFF35 and DFF45 with caspase-activated DNA fragmentation nuclease DFF40.
Gu J; Dong RP; Zhang C; McLaughlin DF; Wu MX; Schlossman SF
J Biol Chem; 1999 Jul; 274(30):20759-62. PubMed ID: 10409614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]